Skin Diseases D012871

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases

Description

Diseases involving the DERMIS or EPIDERMIS.   MeSH

Hierarchy View

Subtype Terms (46)

Acneiform Eruptions
3 drugs (2 approved, 1 experimental)

Angiolymphoid Hyperplasia with Eosinophilia
 

Breast Diseases
68 drugs (54 approved, 14 experimental)

Cutaneous Fistula
 

Dermatitis
30 drugs (20 approved, 10 experimental)

Dermatomyositis
53 drugs (33 approved, 20 experimental)

Erythema
38 drugs (24 approved, 14 experimental)

Exanthema
21 drugs (18 approved, 3 experimental)

Facial Dermatoses
1 approved drug

Foot Diseases
3 approved drugs

Hair Diseases
 

Hand Dermatoses
7 drugs (6 approved, 1 experimental)

Keratoacanthoma
3 approved drugs

Keratosis
16 drugs (7 approved, 9 experimental)

Leg Dermatoses
 

Lipomatosis
 

Lupus Erythematosus, Cutaneous
30 drugs (11 approved, 19 experimental)

Morgellons Disease
 

Nail Diseases
3 drugs (1 approved, 2 experimental)

Necrobiotic Disorders
 

Necrolytic Migratory Erythema
1 approved drug

Nephrogenic Fibrosing Dermopathy
5 drugs (4 approved, 1 experimental)

Panniculitis
1 approved drug

Photosensitivity Disorders
6 drugs (4 approved, 2 experimental)

Pigmentation Disorders
6 approved drugs

Prurigo
13 drugs (7 approved, 6 experimental)

Pruritus
118 drugs (65 approved, 53 experimental)

Pyoderma
3 drugs (1 approved, 2 experimental)

Rosacea
63 drugs (35 approved, 28 experimental)

Scalp Dermatoses
1 approved drug

Scleredema Adultorum
1 experimental drug

Scleroderma, Localized
9 drugs (7 approved, 2 experimental)

Scleroderma, Systemic
139 drugs (80 approved, 59 experimental)

Sebaceous Gland Diseases
 

Skin Abnormalities
9 drugs (2 approved, 7 experimental)

Skin Diseases, Eczematous
9 drugs (8 approved, 1 experimental)

Skin Diseases, Genetic
8 drugs (4 approved, 4 experimental)

Skin Diseases, Infectious
42 drugs (34 approved, 8 experimental)

Skin Diseases, Metabolic
 

Skin Diseases, Papulosquamous
3 drugs (2 approved, 1 experimental)

Skin Diseases, Vascular
 

Skin Diseases, Vesiculobullous
1 approved drug

Skin Neoplasms
131 drugs (76 approved, 55 experimental)

Skin Ulcer
7 drugs (4 approved, 3 experimental)

Sweat Gland Diseases
4 drugs (3 approved, 1 experimental)

Xanthogranuloma, Juvenile
3 drugs (1 approved, 2 experimental)



Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.